Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets
Open Access
- 1 January 2013
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 5 (4), 75-86
- https://doi.org/10.4330/wjc.v5.i4.75
Abstract
The sphingolipid metabolites ceramide, sphingosine, and sphingosine-1-phosphate (S1P) and its enzyme sphingosine kinase (SphK) play an important role in the regulation of cell proliferation, survival, inflammation, and cell death. Ceramide and sphingosine usually inhibit proliferation and promote apoptosis, while its metabolite S1P phosphorylated by SphK stimulates growth and suppresses apoptosis. Because these metabolites are interconvertible, it has been proposed that it is not the absolute amounts of these metabolites but rather their relative levels that determine cell fate. The relevance of this “sphingolipid rheostat” and its role in regulating cell fate has been borne out by work in many labs using many different cell types and experimental manipulations. A central finding of these studies is that SphK is a critical regulator of the sphingolipid rheostat, as it not only produces the pro-growth, anti-apoptotic messenger S1P, but also decreases levels of pro-apoptotic ceramide and sphingosine. Activation of bioactive sphingolipid S1P signaling has emerged as a critical protective pathway in response to acute ischemic injury in both cardiac and cerebrovascular disease, and these observations have considerable relevance for future potential therapeutic targetsKeywords
This publication has 99 references indexed in Scilit:
- Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and functionAdvances in Enzyme Regulation, 2009
- Hypoxic Preconditioning-Induced Cerebral Ischemic ToleranceStroke, 2009
- Cardiomyocyte S1P1 Receptor-mediated Extracellular Signal-related Kinase Signaling and DesensitizationJournal of Cardiovascular Pharmacology, 2009
- Sphingosine Kinase and Sphingosine 1-Phosphate in CardioprotectionJournal of Cardiovascular Pharmacology, 2009
- Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemiaBiochemical and Biophysical Research Communications, 2008
- S1P1 Receptor Localization Confers Selectivity for Gi-mediated cAMP and Contractile ResponsesPublished by Elsevier BV ,2008
- Eukaryotic Elongation Factor 1A Interacts with Sphingosine Kinase and Directly Enhances Its Catalytic ActivityJournal of Biological Chemistry, 2008
- Analysis of sphingosine 1‐phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological toolsBritish Journal of Pharmacology, 2008
- A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC)Prostaglandins & Other Lipid Mediators, 2007
- Distribution of sphingosine kinase activity and mRNA in rodent brainJournal of Neurochemistry, 2007